Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Rigel Pharmaceuticals
Related studies linked through entity extraction aliases.
Related studies linked through entity extraction aliases.